Cell name:
MOLM-13
Other names for the model:
MOLM13、Molm13、Molm 13
Cell information:
MOLM-13 cells are derived from human acute myeloid leukemia
Model information:
Subcutaneous inoculation, the mouse strain is NOD/SCID, and matrix needs to be added during inoculation. Approximately 5 days after vaccination can be grouped, and the administration time after grouping is approximately 16 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059